Insilico Lands $177M Drug Discovery Deal
Polymarket · x · 2026-07-13
China Medical System has agreed to pay Insilico Medicine up to $177 million to develop treatments for central nervous system diseases.
This AI drug discovery collaboration comes with a clear financial cap, demonstrating the continued commercialization of AI drug discovery in the pharmaceutical industry.
More from Venture
- YC F26 startup AnyAlpha launches agentic trading platform that turns ideas into 24/7 trading agents — Scobleizer · 2026-10-27
- Why a seasoned CRO joined LassieAI: Series D-level retention from a 3-person sales team — a16z · 2026-10-27
- Paradev (fka Superset) raises $11.5M seed led by USV to orchestrate armies of coding agents — rebeccakaden · 2026-10-27
- Reuters: China's AI bubble has already burst, $480 billion wiped out — Tennis-Affectionate · 2026-10-27
- Marketing agents are the biggest AI opportunity now — understanding business beats building agents — EXM7777 · 2026-10-27
- Indie newbie goes from first hearing about overseas SEO to first sale in 21 days via new-keyword play — gefei55 · 2026-10-27